Cramer's Lightning Round - Akamai Goes From 'Nah' To 'Yeah' (5/2/13)

Includes: AKAM, AMT, GILD
by: Miriam Metzinger

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday May 2.

Bullish Calls:

Akamai (NASDAQ:AKAM): "This has more room to run. I did a screen for the most insider buying, and Akamai showed up. I said 'Nah, that was such a bad quarter.' But the insiders know more than I do. I think it goes higher."

American Tower (NYSE:AMT): "It is a money machine. Do not sell AMT."

Gilead (NASDAQ:GILD): "Is at $52 and it goes to $60 near term (Cramer added that GILD has the best Hepatitis C drug."

Editor's note: There were no bearish calls on Thursday's program.


Jim Cramer's Action Alerts PLUS: Trade right alongside a Wall Street pro! Start your 14-day FREE trial today.

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.